Teneliptin Tablets 20 mg (Teneligliptin Hydrochloride Hydrate)

Adult dose

The recommended dosage for this medication when used as monotherapy or in combination therapy is 20 mg once daily. It can be taken regardless of meals. Dose adjustment is not necessary for patients with renal impairment. Dose adjustment is not necessary for patients with mild to moderate hepatic impairment.

This medication is used for treating diabetes and should not be administered to certain patients. Patients who are allergic to the active ingredient or any other component of this medication should not take it. Additionally, it is not suitable for patients with diabetic ketoacidosis, diabetic coma, or type 1 diabetes, and those with severe infections or patients undergoing surgery requiring insulin treatment should also avoid this medication. Patients with severe liver dysfunction or heart failure should use this medication with caution, especially if the heart failure is severe. Caution is also required for patients taking sulfonylureas or insulin due to the risk of hypoglycemia. Patients at high risk for hypoglycemia, such as those with pituitary or adrenal insufficiency, malnutrition, erratic meals, intense exercise, or excessive alcohol consumption, should also be careful. Patients with a history of abdominal surgery or bowel obstruction should exercise caution when using this medication. Patients with heart disease, arrhythmias, or hypokalemia, who may be at risk for QT interval prolongation, should avoid this medication. If symptoms of acute pancreatitis occur, it is necessary to seek medical attention immediately, and the medication may need to be discontinued. This medication may cause side effects such as hypoglycemia, constipation, liver dysfunction, interstitial pneumonia, skin rash, and acute pancreatitis, so patients should consult their healthcare provider if any unusual symptoms occur. Particularly, when taken alongside medications like insulin or sulfonylureas that can induce hypoglycemia, patients should monitor for signs of hypoglycemia closely and take appropriate measures if symptoms arise. This medication is not recommended for pregnant or breastfeeding women, nor has its safety in children been established. Elderly patients may have decreased physical functions, so careful observation of the patient's condition during administration is necessary. In cases of overdose, the removal of the medication from the gastrointestinal tract and monitoring of the patient's condition with tests such as ECG, and administering necessary treatment should be performed. This medication should be stored out of reach of children, and transferring it to another container should be avoided. Finally, it is important to consult a physician immediately if symptoms such as hypoglycemia, acute abdominal pain, skin rash, or blisters occur during the use of this medication.

Serious side effects

• Urticaria
• severe swelling (edema)
• hypoglycemia
• liver dysfunction
• interstitial pneumonia
• bullous pemphigoid
• acute pancreatitis
• respiratory distress
• chest pain
• angina

Mild side effects

• Constipation
• dizziness
• headache
• weakness
• hunger
• fatigue
• facial swelling
• diarrhea
• dyspepsia
• nausea

This medication should be stored in a tightly sealed container that does not allow air to enter, and at a temperature between 1 to 30 degrees Celsius. This helps maintain the medication's efficacy and prevent deterioration.

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 60 tablets/bottle